Chemotherapy Without Acute Leukemia As Secondary Diagnosis with Mcc in Nebraska
MS-DRG 846: Chemotherapy without acute leukemia as secondary diagnosis with mcc
$183,245average hospital bill
$45,063average amount paid
One Nebraska hospital reported enough Medicare stays of this kind in 2024 to be listed. It billed an average of $183,245, about 4.1 times what was actually paid. Compare other states.
Billed (list price)Actually paid (Medicare + patient)
| Hospital | City | Medicare stays | Billed | Paid | |
|---|---|---|---|---|---|
| The Nebraska Medical Center | Omaha | 12 | $183,245 | $45,063 |
Medicare: CMS, 2024 (hospitals with 11 or more Medicare stays). Cash and insurer prices: hospitals' own price files, where read; insurer figures are commercial plans only, median and 10th–90th percentile across plans.